FDA Approves First Fecal Transplant Pill

SER-109 is the second human feces-derived treatment to be approved by the FDA. The first was Rebyota in December of 2022.

Nejm
NEJM

C. diff is a bacterial infection that can cause severe diarrhea and inflammation of the colon, and it often recurs even after treatment with antibiotics. According to a recent LIFE-SCIENCE article, the FDA has approved the first-ever pill made from human feces for the treatment of recurrent Clostridioides difficile (C. diff) infection. The pill, called "SER-109," contains spores from multiple strains of bacteria found in healthy feces that can help restore the gut microbiome and fight off C. diff infections.

Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Medical Device Innovations Report
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?